top of page

ADLARITY TRANSDERMAL SYSTEM 10 mg/24 hours

Product details

Registration number: SIN17382P

Classification: Prescription Only

Active ingredients: Donepezil hydrochloride eqv donepezil

Strength: 10 mg/24 hours

Dosage form: PATCH, EXTENDED RELEASE

Route: TRANSDERMAL

Registrant: LOTUS INTERNATIONAL PTE. LTD.

ATC code: N06DA02

HSA approval date: 3 November 2025

Manufacturer(s): Corium Innovations, Inc.

Manufacturing country/countries: UNITED STATES

What are the HSA registration number and classification for ADLARITY TRANSDERMAL SYSTEM 10 mg/24 hours?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN17382P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for ADLARITY TRANSDERMAL SYSTEM 10 mg/24 hours?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Donepezil hydrochloride eqv donepezil

Strength: 10 mg/24 hours

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for ADLARITY TRANSDERMAL SYSTEM 10 mg/24 hours?

According to the HSA dataset updated 7 August 2026:

Dosage form: PATCH, EXTENDED RELEASE

Route: TRANSDERMAL

Source for this answer

Who is the recorded registrant for ADLARITY TRANSDERMAL SYSTEM 10 mg/24 hours?

According to the HSA dataset updated 7 August 2026:

Registrant: LOTUS INTERNATIONAL PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for ADLARITY TRANSDERMAL SYSTEM 10 mg/24 hours?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Corium Innovations, Inc.

Manufacturing country/countries: UNITED STATES

Source for this answer

Where can I look up ADLARITY TRANSDERMAL SYSTEM 10 mg/24 hours in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN17382P or the exact product name ADLARITY TRANSDERMAL SYSTEM 10 mg/24 hours. The general register link does not preselect this product.

Source for this answer

What are the source dates for this ADLARITY TRANSDERMAL SYSTEM 10 mg/24 hours record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this ADLARITY TRANSDERMAL SYSTEM 10 mg/24 hours record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN17382P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page